A detailed history of Core First Bank & Trust transactions in Eli Lilly & CO stock. As of the latest transaction made, Core First Bank & Trust holds 1,000 shares of LLY stock, worth $909,330. This represents 0.61% of its overall portfolio holdings.

Number of Shares
1,000
Previous 1,000 -0.0%
Holding current value
$909,330
Previous $777,000 16.47%
% of portfolio
0.61%
Previous 0.49%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Mar 18, 2024

SELL
$525.19 - $619.13 $105,038 - $123,826
-200 Reduced 16.67%
1,000 $582,000
Q2 2022

Aug 16, 2022

BUY
$278.73 - $327.27 $55,746 - $65,454
200 Added 20.0%
1,200 $389,000
Q2 2021

Aug 17, 2021

SELL
$180.55 - $233.54 $16,249 - $21,018
-90 Reduced 8.26%
1,000 $230,000
Q1 2021

May 18, 2021

BUY
$164.32 - $212.72 $14,788 - $19,144
90 Added 9.0%
1,090 $204,000
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $130,460 - $172,630
1,000 New
1,000 $169,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $864B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Core First Bank & Trust Portfolio

Follow Core First Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core First Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Core First Bank & Trust with notifications on news.